Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Trastuzumab 242 Paclitaxel 223 Fulvestrant 196 Capecitabine 182 Docetaxel 164 Letrozole 142 pembrolizumab 115 Carboplatin 100 exemestane 98 Gemcitabine 98 Cyclophosphamide 92 palbociclib 86 Anastrozole 83 pertuzumab 78 Lapatinib 73 Bevacizumab 71 ribociclib 68 130-nm albumin-bound paclitaxel 66 abemaciclib 59 eribulin 58 Doxorubicin 55 Vinorelbine 51 Injections 47 Ado-Trastuzumab Emtansine 47 Tamoxifen 45 Everolimus 44 Albumin-Bound Paclitaxel 44 atezolizumab 35 trastuzumab deruxtecan 34 Nivolumab 34

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Estriol × Breast × Clear all

NCT02413008 2019-08-05

BLISSAFE

ITF Research Pharma, S.L.U.

Phase 2 Completed

61 enrolled 19 charts

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡